Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia. Multicenter Study Group (Q77952123)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 February 1999

Language	Label	Description	Also known as
English	Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia. Multicenter Study Group	scientific article published on 01 February 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia. Multicenter Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

A Fawzy

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

V Vashi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

N Dias

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Gaffney

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

329-335

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Efficacy and safety of the alpha-1 blocker doxazosin in the treatment of benign prostatic hyperplasia. Analysis of 5 studies. Doxazosin Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

29-week doxazosin treatment in patients with symptomatic benign prostatic hyperplasia. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of doxazosin in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacological studies with doxazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacokinetics of doxazosin in elderly normotensives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic overview of doxazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900506-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(98)00506-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933049%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77952123&oldid=1815142345"